Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Pumpkin roots contain compounds like Alpha-spinasterol, squalene, and palmitic acid, which may have health benefits like reducing depression, treating certain cancers, and having antibacterial properties.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Selenium supplements do not prevent cancer and may have harmful effects.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Finasteride 1 mg may help prevent prostate issues, but more research is needed to confirm its benefits.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Adherence to finasteride treatment for prostate issues is generally low.

β-Sitosterol may help prevent heart disease, cancer, and diabetes, but more human studies are needed.

Tumor proteins can both promote and suppress cancer, depending on the situation.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Finasteride may improve prostate cancer treatment outcomes.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Finasteride significantly reduces prostate cancer risk.

Higher C-peptide levels in African-American men and higher HbA1c levels in Caucasian men are linked to lower PSA levels.

Finasteride may reduce prostate cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Certain Dibenzo derivatives may help treat prostate cancer.

Finasteride improves prostate cancer detection in PSA test.

Finasteride is safe for long-term use in prostate cancer treatment.